DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
ADA566728
Title:
Nano-Engineered Drug Combinations for Breast Cancer Treatment
Descriptive Note:
Annual rept. 15 May 2011-14 May 2012
Corporate Author:
MICHIGAN UNIV ANN ARBOR
Report Date:
2012-06-01
Pagination or Media Count:
10.0
Abstract:
We hypothesis that nanoparticles can increase the efficacy of combination therapies for cancer. The project aims to explore nanoparticle-based transport vehicles for effective delivery of two different cancer drugs. In particular, we aim to use two breast cancer drugs, which enhance each other s efficacy and use them as a model drug pair for the development of novel dual-drug nano-therapeutics. The research to date has been focused on extending existing electrohydrodynamic co-jetting technology in the Lahann lab towards the simultaneous release of two independent small molecule drug surrogates.
Distribution Statement:
APPROVED FOR PUBLIC RELEASE